JACOB ROWLAND: Open Payments
NPI 1578194015 · HAMILTON TOWNSHIP, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,830 in 170 payments from 18 companies in 2025. Trend: 2023 $2,169 · 2024 $2,484 · 2025 $2,830
Food & beverage: $2,830
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $652 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $298 |
| Lilly USA, LLC | 11 | $277 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $261 |
| Gilead Sciences, Inc. | 16 | $232 |
| Ardelyx, Inc. | 15 | $229 |
| PFIZER INC. | 12 | $204 |
| Madrigal Pharmaceuticals | 13 | $192 |
| Phathom Pharmaceuticals, Inc. | 14 | $126 |
| Janssen Biotech, Inc. | 5 | $104 |
Products named: XIFAXAN, OMVOH, IBSRELA, RINVOQ, ENTYVIO, REZDIFFRA, LINZESS, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
